Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112188 · ClinicalTrials.gov registry record
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer
A clinical trial of Advanced Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 84
- Enrollment target
- 9
- Study locations
NCT02112188 is a study of Advanced Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 84 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (66% lower). The trial reports 9 study locations across 2 states.
The verdict
NCT02112188, a study of Advanced Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 84 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of the study is to modify a type of counseling called "Individual Meaning Centered Psychotherapy" to meet the needs of Chinese cancer patients. Many cancer patients use counseling or other resources to help cope with the emotional burden of their illnesses. Counseling often helps them cope with cancer by giving them a place to express their feelings. "Meaning-Centered" counseling aims to teach cancer patients how to maintain or even increase a sense of meaning and purpose in their lives, despite cancer.
Conditions Studied
Interventions
- BEHAVIORAL In-depth Patient Interviews
- BEHAVIORAL Adaptation of IMCP for Chinese Immigrant Cancer Patients
- BEHAVIORAL Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3 and Phase 4)
Study Locations (9)
New York
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- City College of New York (Data Collection AND Data Analysis) - New York
- MSK at Ralph Lauren (Limited Protocol Activities) - New York
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2014-04 |
| Est. Completion | 2027-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112188
The ClinicalTrials.gov registry entry for NCT02112188 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (66% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 3 interventions - of which In-depth Patient Interviews is the first listed.
NCT02112188 reports 9 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02112188 about?
NCT02112188 is a clinical study titled "Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer". The purpose of the study is to modify a type of counseling called "Individual Meaning Centered Psychotherapy" to meet the needs of Chinese cancer patients. Many cancer patients use counseling or other resources to help cope with the emotional burden of their illnesses. Counseling often helps them co...
What is the current status of trial NCT02112188?
This trial is currently active not recruiting. The enrollment target is 84 participants. The study started on 2014-04. Estimated completion is 2027-02-15.
What conditions does trial NCT02112188 study?
This clinical trial studies the following conditions: Advanced Cancer.
What interventions are being tested in trial NCT02112188?
The interventions under investigation include: In-depth Patient Interviews (BEHAVIORAL), Adaptation of IMCP for Chinese Immigrant Cancer Patients (BEHAVIORAL), Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3 and Phase 4) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112188?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02112188 being conducted?
This trial has 9 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Disparities in Precision Oncology
RECRUITING
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RECRUITING · Phase 2
-
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
RECRUITING · NA
-
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
RECRUITING · Phase 1
-
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.